Debangshu Samanta

Debangshu Samanta

Johnson & Johnson Co. - New Jersey / United States
Medical and Health Sciences / Immunology
AD Scientific Index ID: 4394212
-
person_outline Debangshu Samanta's MOST POPULAR ARTICLES
1-) Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNAC Zhang, D Samanta, H Lu, JW Bullen, H Zhang, I Chen, X He, ...Proceedings of the National Academy of Sciences 113 (14), E2047-E2056, 20167712016
2-) Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cellsD Samanta, DM Gilkes, P Chaturvedi, L Xiang, GL SemenzaProceedings of the National Academy of Sciences 111 (50), E5429-E5438, 20144422014
3-) HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cellsH Zhang, H Lu, L Xiang, JW Bullen, C Zhang, D Samanta, DM Gilkes, ...Proceedings of the National Academy of Sciences 112 (45), E6215-E6223, 20152832015
4-) Chemotherapy induces enrichment of CD47+/CD73+/PDL1+ immune evasive triple-negative breast cancer cellsD Samanta, Y Park, X Ni, H Li, CA Zahnow, E Gabrielson, F Pan, ...Proceedings of the National Academy of Sciences 115 (6), E1239-E1248, 20183112018
5-) Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotypeH Lu, D Samanta, L Xiang, H Zhang, H Hu, I Chen, JW Bullen, ...Proceedings of the National Academy of Sciences 112 (33), E4600-E4609, 20152642015